Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

What role does ICER play in US market access?

White Papers and Resources | April 9, 2024 | Petauri Evidence

The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come to market, payers must continue...

Another year, another B!

Press Releases | April 8, 2024 | Cuttsy + Cuttsy

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Streamlining Asynchronous Feedback: Scale Consistency – Impetus InSite Tips #2

Videos and Podcasts | April 4, 2024 | Impetus Digital

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...

Autism Acceptance Week 2024

White Papers and Resources | April 4, 2024 | Mednet

Find out more about autism and how we're supporting autistic people in the workplace

A Woman Should Not Be Treated As a Small Man

Press Releases | April 3, 2024 | Medscape Education

What should the future of women’s healthcare look like? Two renowned physicians say it involves a multidisciplinary, holistic approach, where a group of different specialists work together to provide a...

Mednet Demonstrates £4 Million Social Impact through Groundbreaking Social Return on Investment Methodology

Press Releases | April 2, 2024 | Mednet

Mednet, a leading medical communications agency, has unveiled its inaugural Social Impact Report, showcasing an unprecedented £4 million in social value created across key stakeholders between April 2022 and March...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

White Papers and Resources | April 2, 2024 | Inizio

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How Design Systems enable streamlined regulatory approval in digital pharma

Press Releases | April 2, 2024 | Graphite Digital

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Clinical Trial Protocol Conceptualization: A Customer Story

White Papers and Resources | April 1, 2024 | Impetus Digital

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...

Do omnichannel approaches have a role in market access and payer discussions?

White Papers and Resources | March 28, 2024 | Amiculum

By Frank Fisher and Claire Woon